Abstract
A simple mathematical method to express the deviation in release profile of a test product following Higuchi's kinetics from an ideal Higuchi release profile was developed. The method is based on calculation of area under the curve (AUC) by using the trapezoidal rule. The precision of prediction depends on the number of data points. The method is exemplified for 2 dosage forms (tablets of diltiazem HCl and microspheres of diclofenac sodium) that are designed to release the drug over a 12-hour period. The method can be adopted for the formulations where drug release is incomplete (<100%) or complete (100%) at last sampling time. To describe the kinetics of drug release from the test formulation, zero-order, first-order, Higuchi's. Hixson-Crowell's, and Weibull's models were used. The criterion for selecting the most appropriate model was based on the goodness-of-fit test. The release kinetics of the tablets and microspheres were explained by the Higuchi model. The release profiles of the test batches were slightly below the ideal Higuchi release profile. For the test products, observed percentage deviation from an ideal Higuchi profile is less than 16% for tablets and less than 11% for microspheres. The proposed method can be extended to the modified release formulations that are designed to release a drug over 6, 18, or 24 hours. If the data points are not evenly separated, the ideal drug release profile and AUC are calculated according to the specific sampling time. The proposed method may be used for comparing formulated products during the research and development stage, for quality control of the products, or for promoting products by comparing performance of the test product with that of the innovator's product.
KeyWords: Diltiazem HCl, Modified release, Higuchi model, Kinetics of drug release, Mathematical model
Full Text
The Full Text of this article is available as a PDF (216.0 KB).
References
- 1.Sujja-areevath J, Munday DL, Cox PJ, Khan KA. Relationship between swelling erosion and drug release from hydrophilic natural gum mini-matrix formulations. Eur J Pharm Sci. 1998;6:207–217. doi: 10.1016/S0928-0987(97)00072-9. [DOI] [PubMed] [Google Scholar]
- 2.Chen YW. Fundamentals of controlled release drug administration. In: Swarbrick J, editor. Novel Drug Delivery System. New York, NY: Marcel Dekker., Inc.; 1982. pp. 465–574. [Google Scholar]
- 3.Peppas NA, Sahlin JJ. A simple equation for the description of selute release, III. Coupling of diffusion and relaxation. Int J Pharm. 1989;57:169–172. doi: 10.1016/0378-5173(89)90306-2. [DOI] [Google Scholar]
- 4.Fessi H, Marty J-P, Puisieux F, Carstensen JT. Square root of time dependence of matrix formulation with low drug content. J Pharm Sci. 1982;71:749–752. doi: 10.1002/jps.2600710708. [DOI] [PubMed] [Google Scholar]
- 5.Wiegand RG, Taylor JD. An exponential expression for in vitro release of drug from sustained release preparations. Drug. Std. 1959;27:165–171. [PubMed] [Google Scholar]
- 6.Wagner JG. Sustained action oral medication II. The kinetics of release of drugs to fluid in vitro. Drug Std. 1959;27:178–186. [Google Scholar]
- 7.Higuchi T. Mechanism of sustained action medication theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145–1149. doi: 10.1002/jps.2600521210. [DOI] [PubMed] [Google Scholar]
- 8.Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci. 1961;50:874–875. doi: 10.1002/jps.2600501018. [DOI] [PubMed] [Google Scholar]
- 9.United States Pharmacopoeta XXIII . Supplement 8. Rockyille MD: United States Pharmacopoeial Convention, Inc.; 1998. pp. 4199–4199. [Google Scholar]
- 10.Bolton S, editor. Pharmaceutical Statisties. 2nd ed. New York: NY Marcel Dekker, Inc; 1990. pp. 234–236. [Google Scholar]
- 11.Gohel MC, Panchal MK. Formulation optimization of diltiazem HCl matrix tablets containing modified guar gum using a central composite design. Pharm Pharmacol Commun. 1999;5:331–338. [Google Scholar]
- 12.Bamba M, Puisieusx F, Marty JP, Carstensen JT. Release mechanisms in gel forming sustained release preparations. Int J Pharm. 1979;2:307–315. doi: 10.1016/0378-5173(79)90037-1. [DOI] [Google Scholar]
- 13.Gohel MC, Amin AF. Formulation optimization of controlled release diclofenac sodium microspheres using factoral design. J Control Rel. 1998;51:115–122. doi: 10.1016/S0168-3659(97)00102-8. [DOI] [PubMed] [Google Scholar]